The MATISSE study: a randomised trial of group art therapy for people with schizophrenia.
BACKGROUND
Art Therapy has been promoted as a means of helping people who may find it difficult to express themselves verbally engage in psychological treatment. Group Art Therapy has been widely used as an adjunctive treatment for people with schizophrenia but there have been few attempts to examine its effects and cost effectiveness has not been examined. The MATISSE study aims to evaluate the clinical and cost effectiveness of group Art Therapy for people with schizophrenia.


METHODS
The MATISSE study is a three-arm, parallel group, pragmatic, randomised, controlled trial of referral to group Art Therapy plus standard care, referral to an attention control 'activity' group plus standard care, or standard care alone. Study participants were recruited from inpatient and community-based mental health and social care services at four centres in England and Northern Ireland. Participants were aged over 18 years with a clinical diagnosis of schizophrenia, confirmed by an examination of case notes using operationalised criteria. Participants were then randomised via an independent and remote telephone randomisation service using permuted stacked blocks, stratified by site. Art Therapy and activity groups were made available to participants once a week for up to 12 months. Outcome measures were assessed by researchers masked to allocation status at 12 and 24 months after randomisation. Participants and care givers were aware which arm of the trial participants were allocated to. The primary outcomes for the study are global functioning (measured using the Global Assessment of Functioning scale) and mental health symptoms (measured using the Positive and Negative Syndrome Scale) assessed at 24 months. Secondary outcomes were assessed at 12 and 24 months and comprise levels of group attendance, social function, satisfaction with care, mental wellbeing, and costs.


CONCLUSIONS
We believe that this is the first large scale pragmatic trial of Art Therapy for people with schizophrenia.


BACKGROUND
Current Controlled Trials ISRCTN46150447.
Crawford
Mike J
MJ
Centre for Mental Health, Imperial College, Claybrook Road London, W6 8LN, UK. m.crawford@imperial.ac.uk
Killaspy
Helen
H
Kalaitzaki
Eleftheria
E
Barrett
Barbara
B
Byford
Sarah
S
Patterson
Sue
S
Soteriou
Tony
T
O'Neill
Francis A
FA
Clayton
Katie
K
Maratos
Anna
A
Barnes
Thomas R
TR
Osborn
David
D
Johnson
Tony
T
King
Michael
M
Tyrer
Peter
P
Waller
Diana
D
D000328:Adult; D001155:Art Therapy / Q000191:economics / Q000379:methods*; D003072:Cognition Disorders / Q000523:psychology; D003362:Cost-Benefit Analysis; D004739:England; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D009660:Northern Ireland; D011615:Psychotherapy, Group / Q000191:economics / Q000379:methods*; D012559:Schizophrenia / Q000191:economics / Q000628:therapy*; D012565:Schizophrenic Psychology; D016896:Treatment Outcome
BMJ. 2000 Apr 29;320(7243):1197-200
10784550
Psychol Med. 2004 Apr;34(3):413-22
15259826
Am J Psychiatry. 1994 Oct;151(10):1409-16
8092334
Br J Psychiatry. 2006 Nov;189:405-9
17077429
Schizophr Bull. 1987;13(2):261-76
3616518
Br J Psychiatry. 2005 Aug;187:106-8
16055820
J Ment Health. 2002;11(2):191-8
21208145
Br J Psychiatry. 1998 Nov;173:376-84
9926053
Int J Soc Psychiatry. 2005 Sep;51(3):265-75
16252794
Acta Psychiatr Scand. 2000 Oct;102(4):303-9
11089732
Stat Med. 2005 Apr 15;24(7):993-1007
15570623
Evid Based Ment Health. 2007 Aug;10(3):69-70
17652554
Br J Psychiatry. 1995 Nov;167(5):596-603
8564314
J Ment Health. 2010 Dec;19(6):532-41
21121823
Drug Alcohol Depend. 2006 Jan 4;81(1):47-54
16006055
Schizophr Bull. 2006 Oct;32 Suppl 1:S64-80
16905634
Hosp Community Psychiatry. 1987 Sep;38(9):988-91
3679106
J Consult Clin Psychol. 2008 Dec;76(6):966-78
19045965
Arch Gen Psychiatry. 1991 Aug;48(8):764-70
1883262
Health Econ. 1994 Sep-Oct;3(5):309-19
7827647
Clin Trials. 2005;2(2):152-62
16279137
J Clin Epidemiol. 2009 May;62(5):464-75
19348971
BMJ. 2008 Sep 29;337:a1655
18824488
Health Policy. 1996 Jul;37(1):53-72
10158943
Stat Med. 1991 Jan;10(1):45-52
2006355
Arch Gen Psychiatry. 1999 Mar;56(3):241-7
10078501
Br J Clin Pharmacol. 2000 Aug;50(2):166-71
10930969
Can J Psychiatry. 2002 Nov;47(9):833-43
12500753
Arch Gen Psychiatry. 1982 Jul;39(7):789-94
7165478
Br J Psychiatry. 1995 May;166(5):654-9
7620753
Cochrane Database Syst Rev. 2005 Oct 19;(4):CD003728
16235338
BMJ. 2005 Jan 15;330(7483):142-4
15649931
BMJ. 1996 Feb 10;312(7027):345-9
8611831